- Home
- DAWN vs CLBK Comparison
DAWN vs CLBK Comparison
Compare DAWN & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- CLBK
- Stock Information
- Founded
- DAWN 2018
- CLBK 1927
- Country
- DAWN United States
- CLBK United States
- Employees
- DAWN N/A
- CLBK N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- CLBK Savings Institutions
- Sector
- DAWN Health Care
- CLBK Finance
- Exchange
- DAWN Nasdaq
- CLBK Nasdaq
- Market Cap
- DAWN 1.6B
- CLBK 1.5B
- IPO Year
- DAWN 2021
- CLBK N/A
- Fundamental
- Price
- DAWN $13.34
- CLBK $18.19
- Analyst Decision
- DAWN Strong Buy
- CLBK Hold
- Analyst Count
- DAWN 7
- CLBK 1
- Target Price
- DAWN $36.17
- CLBK $17.00
- AVG Volume (30 Days)
- DAWN 1.3M
- CLBK 86.8K
- Earning Date
- DAWN 10-30-2024
- CLBK 10-24-2024
- Dividend Yield
- DAWN N/A
- CLBK N/A
- EPS Growth
- DAWN N/A
- CLBK N/A
- EPS
- DAWN N/A
- CLBK 0.15
- Revenue
- DAWN $101,953,000.00
- CLBK $201,023,000.00
- Revenue This Year
- DAWN N/A
- CLBK N/A
- Revenue Next Year
- DAWN $44.21
- CLBK $11.72
- P/E Ratio
- DAWN N/A
- CLBK $121.85
- Revenue Growth
- DAWN N/A
- CLBK N/A
- 52 Week Low
- DAWN $11.30
- CLBK $13.79
- 52 Week High
- DAWN $18.07
- CLBK $20.46
- Technical
- Relative Strength Index (RSI)
- DAWN 38.64
- CLBK 54.97
- Support Level
- DAWN $12.86
- CLBK $17.71
- Resistance Level
- DAWN $13.71
- CLBK $19.26
- Average True Range (ATR)
- DAWN 0.77
- CLBK 0.56
- MACD
- DAWN -0.25
- CLBK -0.04
- Stochastic Oscillator
- DAWN 12.24
- CLBK 58.20
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About CLBK Columbia Financial Inc.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.